Filtered By:
Therapy: Neoadjuvant Therapy
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 9957 results found since Jan 2013.
Real-life benchmarking bladder cancer care: A population-based study
CONCLUSIONS: Performance through most bladder cancer quality-of-care indicators fall short of benchmarks proposed by expert opinion. Different methodologies, such as a paredmean approach of top performers, may provide more realistic benchmarking.PMID:37581551 | PMC:PMC10426426 | DOI:10.5489/cuaj.8231
Source: Canadian Urological Association Journal - August 15, 2023 Category: Urology & Nephrology Authors: Nicolas Vanin Moreno Marlo Whitehead D Robert Siemens Source Type: research
Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
CONCLUSION: The addition of carboplatin to standard NACT in stages II and III TNBC was associated with a non-statistically significant numerical increase in the pCR rate. Follow-up for survival outcomes and translational research initiatives are ongoing.PMID:37578666 | DOI:10.1007/s10549-023-07011-0
Source: Cancer Control - August 14, 2023 Category: Cancer & Oncology Authors: Cristiano de P ádua Souza Ana Suellen Barroso Carneiro Ana Cec ília de Oliveira Lessa Dom ício Carvalho Lacerda Carlos Eduardo Paiva Marina Moreira Costa Zorzetto Ana Julia Aguiar de Freitas Iara Viana Vidigal Santana Marco Antonio de Oliveira Edenir I Source Type: research
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy
CONCLUSION: Our findings suggested that TPC combination could be a cost-saving option in patients with HER2+BC at high-risk of recurrence.PMID:37573652 | DOI:10.1016/j.breast.2023.08.005
Source: Breast - August 13, 2023 Category: Cancer & Oncology Authors: Alberto Zambelli Marina Cazzaniga Nicla La Verde Elisabetta Munzone Ippazio Cosimo Antonazzo Lorenzo Giovanni Mantovani Serena Di Cosimo Anna Mancuso Daniele Generali Paolo Angelo Cortesi Source Type: research
ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer
Ann Surg Oncol. 2023 Aug 14. doi: 10.1245/s10434-023-14097-9. Online ahead of print.NO ABSTRACTPMID:37574519 | DOI:10.1245/s10434-023-14097-9
Source: Ann Oncol - August 13, 2023 Category: Cancer & Oncology Authors: Kai Huang James Jakub Emmanuel Gabriel Alvaro Moreno-Aspitia Sarah McLaughlin Source Type: research
